Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Alaupovic

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
Journal of Lipid Research|January 11, 1991
Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemiaP Alaupovic, C Knight-Gibson, C S Wang, et al.
Journal of Chromatography|July 12, 1985
Evaluation of immunoaffinity chromatography for isolating human lipoproteins containing apolipoprotein BW J McConathy, E Koren, H Wieland, et al.
Circulation|November 1, 1995
Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trialA M Shircore, W J Mack, R H Selzer, et al.
Atherosclerosis|November 1, 1982
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipaseW C Breckenridge, J A Little, P Alaupovic, et al.
The New England Journal of Medicine|October 26, 1978
Metabolism of high-density lipoprotein apolipoproteins in Tangier diseaseE J Schaefer, C B Blum, R I Levy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 1997
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiencyO Samuelsson, H Mulec, C Knight-Gibson, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
apoB-containing lipoprotein particles as risk factors for coronary artery diseaseP Alaupovic, D H Blackenhorn, C Knight-Gibson, et al.
Circulation|October 18, 2000
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trialF M Sacks, P Alaupovic, L A Moye, et al.
Atherosclerosis|August 1, 1992
Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP)E Koren, V W Armstrong, G Mueller, et al.
Kidney International|April 14, 1999
Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysisP O Attman, O G Samuelsson, J Moberly, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Journal of Lipid Research|January 11, 1991
Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II:B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemiaP Alaupovic, C Knight-Gibson, C S Wang, et al.
Journal of Chromatography|July 12, 1985
Evaluation of immunoaffinity chromatography for isolating human lipoproteins containing apolipoprotein BW J McConathy, E Koren, H Wieland, et al.
Circulation|November 1, 1995
Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trialA M Shircore, W J Mack, R H Selzer, et al.
Atherosclerosis|November 1, 1982
Lipoprotein abnormalities associated with a familial deficiency of hepatic lipaseW C Breckenridge, J A Little, P Alaupovic, et al.
The New England Journal of Medicine|October 26, 1978
Metabolism of high-density lipoprotein apolipoproteins in Tangier diseaseE J Schaefer, C B Blum, R I Levy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 5, 1997
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiencyO Samuelsson, H Mulec, C Knight-Gibson, et al.
Advances in Experimental Medicine and Biology|January 1, 1991
apoB-containing lipoprotein particles as risk factors for coronary artery diseaseP Alaupovic, D H Blackenhorn, C Knight-Gibson, et al.
Circulation|October 18, 2000
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trialF M Sacks, P Alaupovic, L A Moye, et al.
Atherosclerosis|August 1, 1992
Apolipoprotein A-I and apolipoprotein B containing lipoprotein particles in coronary patients treated with extracorporal low density lipoprotein precipitation (HELP)E Koren, V W Armstrong, G Mueller, et al.
Kidney International|April 14, 1999
Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysisP O Attman, O G Samuelsson, J Moberly, et al.
Pageof 19